In line with this finding, an ICC study comparing paired primary and recurrent tumors showed that 80% (4/5) of IDH mutations were only detected in the recurrent tumors, indicating non‐truncal status.[50]. This evidence concerns the gene IDH2 and intrahepatic cholangiocarcinoma.